MNOV

MediciNova to Conduct Mouse Study under Partnership with BARDA to Develop MN-166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury

MediciNov Sees Volume After Zacks Research Raises Price Target To $28

Hot Reddit Penny Stocks to Buy? 10 That You Should Know About

MNOV Stock Price Increases Over 30%: Why It Happened

MediciNova Announces Positive Results from Phase 2 Trial of MN-166 (ibudilast) in Alcohol Use Disorder Published in Nature's Translational Psychiatry Journal

MediciNova to Participate in Maxim Group LLC Fireside Chat

MediciNova Initiates Sheep Study under Partnership with BARDA to Develop MN-166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury